11 results for author:"Paris D." in Literature citations
Results Customize
› Repeat search in UniProtKB (41)
| Epitope-dependent effects of Beta-amyloid antibodies on Beta-amyloid clearance in an in vitro model of the blood-brain barrier. Bachmeier C.J., Beaulieu-Abdelahad D., Mullan M.J., Paris D. Microcirculation 18:373-379(2011) · Mapped (10) |
| Selective antihypertensive dihydropyridines lower Abeta accumulation by targeting both the production and the clearance of Abeta across the blood-brain barrier. Paris D., Bachmeier C., Patel N., Quadros A., Volmar C.H., Laporte V., Ganey J., Beaulieu-Abdelahad D., Ait-Ghezala G., Crawford F. et al. Mol. Med. 17:149-162(2011) · Mapped (19) |
| Isolation of a novel Orientia species (O. chuto sp. nov.) from a patient infected in Dubai. Izzard L., Fuller A., Blacksell S.D., Paris D.H., Richards A.L., Aukkanit N., Nguyen C., Jiang J., Fenwick S., Day N.P. et al. J. Clin. Microbiol. 48:4404-4409(2010) · UniProtKB (2) |
| Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. Patel N.S., Mathura V.S., Bachmeier C., Beaulieu-Abdelahad D., Laporte V., Weeks O., Mullan M., Paris D. J. Neurochem. 112:66-76(2010) · Mapped (17) |
| Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease. Ait-ghezala G., Abdullah L., Volmar C.H., Paris D., Luis C.A., Quadros A., Mouzon B., Mullan M.A., Keegan A.P., Parrish J. et al. Cytokine 44:283-287(2008) · Mapped (18) |
| The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production. Volmar C.H., Ait-Ghezala G., Frieling J., Paris D., Mullan M.J. Cytokine 42:336-344(2008) · Mapped (12) |
| Genetic typing of the 56-kDa type-specific antigen gene of contemporary Orientia tsutsugamushi isolates causing human scrub typhus at two sites in north-eastern and western Thailand. Blacksell S.D., Luksameetanasan R., Kalambaheti T., Aukkanit N., Paris D.H., McGready R., Nosten F., Peacock S.J., Day N.P. FEMS Immunol. Med. Microbiol. 52:335-342(2008) · UniProtKB (18) |
| The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene. Forrest S.M., Knight M., Delatycki M.B., Paris D., Williamson R., King J., Yeung L., Nassif N., Nicholson G.A. Neurogenetics 1:253-257(1998) · UniProtKB (1) |
| Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E. Town T., Paris D., Parker T.A., Kundtz A., Tan J., Duara R., Gold M., Crawford F., Mullan M. Am. J. Med. Genet. 88:465-468(1999) · Mapped (5) |
| The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M. Neurosci. Lett. 252:95-98(1998) · Mapped (5) |
| Genomic organization of the human cystathionine beta-synthase gene: evidence for various cDNAs. Chasse J.-F., Paly E., Paris D., Paul V., Sinet P.-M., Kamoun P., London J. Biochem. Biophys. Res. Commun. 211:826-832(1995) · UniProtKB (1) |